Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II. Observation of a hierarchy among dominant antigens
- PMID: 2426194
- DOI: 10.1007/BF00372294
Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II. Observation of a hierarchy among dominant antigens
Abstract
Immunization of C57BL/6 mice with BALB.B spleen cells in vivo and subsequent boosting in mixed lymphocyte culture result in the generation of cytolytic T lymphocytes (CTLs) which are specific for a limited number of immunodominant antigens. Experiments are described which suggest the existence of a hierarchy of immunodominance in this donor: host combination. Two antigens, CTT-1.3 and CTT-2.3, are dominant in the C57BL/6 anti-BALB.B CTL response. The distribution of these antigens among CXB recombinant inbred (RI) strains suggests that they segregate as single gene traits. Elimination of the CTT-1.3 and CTT-2.3 antigens by complementation in the responder, or elimination from the priming and boosting stages by the selection of CXB RI strain mice as responders or stimulators, reveals a second level of immunodominant antigens which include CTT-3.3 and CTT-4.3. CXB mice which express one of the CTT-1.3 or CTT-2.3 antigens will produce CTLs specific for the other antigen upon priming and boosting with BALB.B cells. Expression of both antigens in responders results in the generation of CTLs specific for the second level, dominant antigens. Immunodominance is not confined to the C57BL/6 anti-BALB.B system but can also be observed in the BALB.B anti-C57BL/6 and B10.D2 anti-DBA/2 systems. Finally, generation of CTLs following priming and boosting with dominant and dominated antigens presented on different cells confirmed that immunodominance can only be observed when the dominant and dominated antigens are presented on the same cells. These observations suggest that immunodominance is revealed at the level of antigen-presenting cells primarily involved in vivo priming.
Similar articles
-
Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.J Immunol. 1987 Oct 1;139(7):2166-71. J Immunol. 1987. PMID: 2958540
-
Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules.Transplantation. 1997 Nov 15;64(9):1323-30. doi: 10.1097/00007890-199711150-00015. Transplantation. 1997. PMID: 9371675
-
Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.Transplantation. 1998 Feb 27;65(4):559-69. doi: 10.1097/00007890-199802270-00018. Transplantation. 1998. PMID: 9500633
-
DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.Ann N Y Acad Sci. 1995 Nov 27;772:64-76. doi: 10.1111/j.1749-6632.1995.tb44732.x. Ann N Y Acad Sci. 1995. PMID: 8546414 Review.
-
Exposing the immunology of naked DNA vaccines.Immunity. 1995 Aug;3(2):165-9. doi: 10.1016/1074-7613(95)90085-3. Immunity. 1995. PMID: 7648389 Review. No abstract available.
Cited by
-
Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. V. Chromosomal mapping of the immunodominant cytotoxic T-cell target-1 (CTT-1).Immunogenetics. 1993;38(2):157-60. doi: 10.1007/BF00190905. Immunogenetics. 1993. PMID: 8482579 No abstract available.
-
Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?Cancer Immunol Immunother. 1995 Nov;41(5):265-70. doi: 10.1007/BF01517213. Cancer Immunol Immunother. 1995. PMID: 8536271 Free PMC article. Review. No abstract available.
-
Characterization of CTL Clones Specific for Single Antigen, H60 Minor Histocompatibility Antigen.Immune Netw. 2011 Apr;11(2):100-6. doi: 10.4110/in.2011.11.2.100. Epub 2011 Apr 30. Immune Netw. 2011. PMID: 21637387 Free PMC article.
-
Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice.Clin Exp Immunol. 2003 Apr;132(1):46-52. doi: 10.1046/j.1365-2249.2003.02115.x. Clin Exp Immunol. 2003. PMID: 12653835 Free PMC article.
-
Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen.J Exp Med. 2000 May 15;191(10):1687-98. doi: 10.1084/jem.191.10.1687. J Exp Med. 2000. PMID: 10811862 Free PMC article.